About
CrystalsFirst GmbH provides a platform combining patented high-throughput structural biology techniques with AI-driven drug design to accelerate and optimize small-molecule drug discovery through fragment screening and ligand identification.
Explore CrystalsFirst GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.